about
Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trialResponse to imported case of Marburg hemorrhagic fever, the NetherlandMass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever.Clinical evaluation of viral acute respiratory tract infections in children presenting to the emergency department of a tertiary referral hospital in the Netherlands.Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes.Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study.Human bocavirus in an immunocompromised child presenting with severe diarrhea.Cytokines in clinical and experimental transplantation.Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states.Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers.Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications.How to use... neonatal TORCH testing.The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model.Marburg hemorrhagic fever in returning travellers: an overview aimed at clinicians.Neonatal screening parameters in infants with congenital Cytomegalovirus infection.Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications.Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy.Congenital Cytomegalovirus Infection: Child Development, Quality of Life and Impact on Daily Life.The association between foodborne and orofecal pathogens and allergic sensitisation -- EuroPrevall study.Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence.Diagnostic performance of serological assays for anti-HBs testing: Results from a quality assessment program.T and B Cell Markers in Dried Blood Spots of Neonates with Congenital Cytomegalovirus Infection: B Cell Numbers at Birth Are Associated with Long-Term Outcomes.Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs.Modulation of systemic cytokine levels by implantation of alginate encapsulated cells.Genetic and antigenic structural characterization for resistance of echovirus 11 to pleconaril in an immunocompromised patient.Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara).Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance.Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients.Awareness of congenital cytomegalovirus among doctors in the Netherlands.Is routine TORCH screening warranted in neonates with lenticulostriate vasculopathy?Diagnostic and therapeutic management for suspected neonatal herpes simplex virus infection.Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrations.Rapid susceptibility testing for herpes simplex virus type 1 using real-time PCR.Persistence and antiviral resistance of varicella zoster virus in hematological patients.Atypical varicella zoster infection associated with hemophagocytic lymphohistiocytosis.
P50
Q21092218-C307550E-002D-4910-9C92-FBB6D51B2484Q33502911-80C980C4-C5DC-4325-A8E4-677C89C4D3EFQ33841585-FACBEEF2-7A61-4EDF-AD6F-0D705131BD4BQ34186562-FC86BD8B-4375-4D6C-B0E2-FF498C0F3E8FQ34769155-FA1A70BA-4F0A-4865-A97B-0B182681770FQ35689180-B0FF68BD-F092-4E51-AB1F-809AE081AD7FQ36341023-E1FCAF0B-16F5-4F79-9EA3-249EE4ED755DQ37156790-7E799EE0-2AAF-4E78-9E7C-CE664A40E225Q37162174-A13DAD9B-DC68-47D7-8293-C778B1A4F849Q37459426-92515F93-55C2-4A40-BBB0-CB96775A3EAEQ37829983-53C3D468-FF37-4FAC-BD6E-5B8E627E7851Q37976238-3309F2D8-AA87-4931-9B64-EB0D09052D0FQ38087436-9D04002E-3399-4BB5-8AD6-6BC2AEB92503Q38096348-D7381F95-DDF1-4C29-90FD-785647CF1410Q38210881-4B0F36C6-28BF-41AE-8F82-60E4C0DC31FDQ38605258-C3FBBC7D-E0B1-4B5E-847F-AAC2170A7ADFQ39054189-EA7990A8-842B-4A9A-88A4-3D807F7581F1Q39209399-9B020A7A-54EE-4DE6-A296-45A07D39B2A2Q40145391-7049143F-F4D9-4C7B-BADC-D0B5A3CF0A20Q40156773-EEB52508-8FEA-466D-A836-096E96AC5236Q40337545-4800D71D-E7BE-4693-B572-136B69782D12Q40405828-BA139B6C-ACC8-4E6A-827B-7A6F8630D99DQ40428945-FF416AA7-1F52-475F-9ADA-37F7F518F6FBQ40698149-D0D6C93E-3E17-4609-94D2-8D5400B6576FQ41474034-A66AAC25-C395-4AF0-BF8B-780F300EE9AFQ41662491-370A7466-3DF5-47B9-9F10-927287821C6BQ42242630-962EB4E2-C712-4215-92D2-D04BCD9BBF3EQ42281956-E4AD0DE4-5D34-4DE9-8892-B6310521E23AQ43078075-E2406032-F9F9-4CD8-92B7-3729E1DAD45AQ43166686-96E334F2-B66C-48D6-B11E-FAB1616E3A49Q43542844-27BA9D72-36F7-45C2-8D37-259E06F738A5Q43554200-818CF072-5282-40C4-8D2F-BB511AFBC164Q43564701-F97DAA31-83C3-4317-A361-B0233BF7F2E5Q43662020-EF45E29C-DE96-4E45-AF5F-42E9BAA56747Q43684819-C8CD2712-DEBF-49A4-A1D5-80B1407878D5Q43993351-198A3B66-67F5-49DE-B416-EBB08BB7833BQ44585213-AC89B6BB-0321-4C2A-8097-776D0E585809Q44642932-2EE01AEA-0570-45F6-8CC7-8BDEEE4D6B15Q45354319-AB45AFF8-BCA7-4539-9F56-7361AB6E5F5FQ46057296-A8AF97A0-C8A6-4C16-AE20-D3E2DF40E7FB
P50
description
associate professor
@en
hulumtuese
@sq
universitair hoofddocent aan het LUMC
@nl
հետազոտող
@hy
name
Ann C Vossen
@sl
Ann C. Vossen
@es
Ann Vossen
@en
Ann Vossen
@fr
Ann Vossen
@nl
type
label
Ann C Vossen
@sl
Ann C. Vossen
@es
Ann Vossen
@en
Ann Vossen
@fr
Ann Vossen
@nl
altLabel
A.C.T.M Vossen
@nl
prefLabel
Ann C Vossen
@sl
Ann C. Vossen
@es
Ann Vossen
@en
Ann Vossen
@fr
Ann Vossen
@nl
P1006
P214
P1006
P1153
6701661973
P21
P214
P2798
P31
P496
0000-0003-1750-2843